Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03247803 · ClinicalTrials.gov registry record · NA
Air-Q® SP Versus Williams Intubating Airway for Single-Operator FOI
A NA study of Intubation; Difficult or Failed and Laryngeal Masks, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT03247803: Completed NA study of Intubation; Difficult or Failed and Laryngeal Masks, sponsored by University of Wisconsin, Madison.
NCT03247803 is a NA study of Intubation; Difficult or Failed and Laryngeal Masks that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03247803, a NA study of Intubation; Difficult or Failed and Laryngeal Masks, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The air-Q and air-Q SP are commercially-available supraglottic airways (SGAs) that can be used for primary airway maintenance or as a conduit for FOI, as can be the Williams, Ovassapian, and Berman Intubating Airways. The air-Q products have the same overall geometrical design, but differ in their cuff inflating mechanisms, where the air-Q uses a traditional pilot balloon valve, while the air-Q SP utilizes a self-inflating cuff that dynamically adjusts according to the relative resistances to airflow between the patient's lungs and the device's cuff. The purpose of this study is to compare the single-operator intubation success using the air-Q SP versus the Williams Intubating Airway as a conduit for flexible bronchoscopic intubation (FBI) and to compare the single-operator intubation success using the air-Q SP versus the Williams Intubating Airway as a conduit for flexible bronchoscopic intubation. Both devices are commercially-available and being used in the study in accordance with their labeled intended use. The investigator envisage that the endpoint of the study will be single operator intubation success rate.
Primary Outcome
The primary purpose of this study is to compare the single-operator intubation success using the air-Q SP versus the Williams Intubating Airway as a conduit for flexible bronchoscopic intubation.
Conditions Studied
Interventions
- DEVICE air-Q® SP
- DEVICE Williams Airway Intubator (WA)
Study Locations (1)
Wisconsin
- University of Wisconsin Hopital and Clinics - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-06-11 |
| Est. Completion | 2019-03-08 |
| Phase | NA |
What the finished NCT03247803 record still lists
NCT03247803 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Intubation; Difficult or Failed appearing as the primary indexed condition, and to 2 interventions - of which air-Q® SP is the first listed.
NCT03247803 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT03247803 about?
NCT03247803 is a clinical study titled "Air-Q® SP Versus Williams Intubating Airway for Single-Operator FOI". The air-Q and air-Q SP are commercially-available supraglottic airways (SGAs) that can be used for primary airway maintenance or as a conduit for FOI, as can be the Williams, Ovassapian, and Berman Intubating Airways. The air-Q products have the same overall geometrical design, but differ in their c...
What is the current status of trial NCT03247803?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2018-06-11. Estimated completion is 2019-03-08.
What conditions does trial NCT03247803 study?
This clinical trial studies the following conditions: Intubation; Difficult or Failed, Laryngeal Masks.
What interventions are being tested in trial NCT03247803?
The interventions under investigation include: air-Q® SP (DEVICE), Williams Airway Intubator (WA) (DEVICE).
Who is sponsoring clinical trial NCT03247803?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03247803 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intubation; Difficult or Failed
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03247803's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI